DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Thill M, Schmidt M.
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer.

Ther Adv Med Oncol 2018;
10: 1758835918793326
doi:10.1177/1758835918793326

Download Bibliographical Data

Access:
Access: